Changeflow GovPing Healthcare & Life Sciences Alert on Counterfeit Proguanil Tablets (Projean...
Urgent Enforcement Added Final

Alert on Counterfeit Proguanil Tablets (Projeanil and Re-granil) Found in Nigeria

Favicon for nafdac.gov.ng NAFDAC Nigeria News & Alerts
Filed
Detected
Email

Summary

NAFDAC issued Public Alert No. 023/2026 warning of counterfeit Proguanil tablets (Projeanil and Re-granil, both 100mg B.P.) bearing fake NAFDAC Registration Number 04-6433 in Nigeria. The fraudulent registration number belongs to Feroglobin B12 Capsules by Vitabiotics Nigeria, not the counterfeit antimalarial products. NAFDAC zonal directors and state coordinators have been directed to conduct surveillance and remove any products found in circulation. Healthcare professionals, distributors, retailers, and caregivers are advised to verify product authenticity, avoid unauthorized suppliers, and report any suspected falsified products.

“Falsified, counterfeit, and unregistered medicines significantly threaten public health because they have not been evaluated in the lab, and their quality, safety, and efficacy cannot be assured.”

NAFDAC , verbatim from source
Published by NAFDAC on nafdac.gov.ng . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

GovPing monitors NAFDAC Nigeria News & Alerts for new healthcare & life sciences regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 3 changes logged to date.

What changed

NAFDAC issued Public Alert No. 023/2026 warning of two counterfeit antimalarial products—Projeanil (manufactured by Apple King Industry PVT, New Delhi) and Re-granil (manufactured by Jamila Export LAB., Mumbai)—both bearing fake NAFDAC Registration Number 04-6433. The genuine registration belongs to Feroglobin B12 Capsules manufactured by Vitabiotics Nigeria. Distributors, retailers, healthcare professionals, and caregivers should verify product authenticity, obtain medicines only from authorized or licensed suppliers, and report any suspected falsified or compromised products to the nearest NAFDAC office, call 0800-162-3322, or email sf.alert@nafdac.gov.ng. Adverse events related to these or any other medicinal products should also be reported through NAFDAC's E-reporting platforms or the Med-safety application.

Archived snapshot

Apr 25, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Also In Recalls and Safety Alerts

March 25, 2026

The National Agency for Food and Drugs Administration and Control (NAFDAC) is informing healthcare professionals and the general public of the circulation of counterfeit brands of Proguanil tablets, specifically Projeanil and Re-granil, both at 100 mg B.P.

The NAFDAC Registration Number (NRN) 04-6433 displayed on the products belongs to a different registered product Feroglobin B12 Capsules by Vitabiotics Nigeria. This finding raises serious concerns regarding the circulation of counterfeit products in the market.

Proguanil is an antimalarial medication, commonly used in combination with atovaquone (Malarone) or chloroquine to prevent and treat malaria, particularly Plasmodium falciparum.

Risk Statement

Falsified, counterfeit, and unregistered medicines significantly threaten public health because they have not been evaluated in the lab, and their quality, safety, and efficacy cannot be assured.

Falsified Product details

The details of the products are as follows:

| Product Name | Projeanil (Proguanil Tablet B.P 100mg) | Re-Granil (Proguanil Tablet B.P 100mg) |
| Stated Manufacturer | Apple King Industry PVT 253, A/2 Shapujat, New Delhi, India | Jamila Export LAB. PVT LTD. 401 Indraluse Estate, Mumbai Batal, India |
| Agent | Lifemore, 111 All Way, Ibadan | Desmons Laboratory, 70 Ajibade Avenue, Ibadan |
| Batch Number | BN600 | BN600 |
| Manufacturing Date | 08/2024 | 08/2022 |
| Expiry Date | 09/2028 | 09/2027 |
| Fake NAFDAC Reg. No. | 04-6433 | 04-6433 |
Product Photo

NAFDAC remains committed to safeguarding public health and will continue surveillance activities to ensure the quality, safety, and efficacy of medicines, medical devices, and other regulated products circulating in Nigeria.

All NAFDAC zonal directors and state coordinators have been directed to conduct surveillance and remove any products found in their zones and states.

Distributors, retailers, healthcare professionals, and caregivers are advised to exercise caution and vigilance regarding the counterfeit products and to refrain from distributing, selling, or using them. All medical products must be obtained from authorized or licensed suppliers. The authenticity and physical condition of these products should be carefully checked before use.

Healthcare professionals are advised to review stocks within hospitals, clinics, and pharmacy stores, report any suspected falsified or compromised products (medicines or medical devices) to the nearest NAFDAC office, call NAFDAC on 0800-162-3322, or via email: sf.alert@nafdac.gov.ng

Similarly, healthcare professionals and patients are also encouraged to report adverse events or side effects related to the use of medicinal products or devices to the nearest NAFDAC office, or through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng, or via the Med-safety application available for download on Android and IOS stores, or via e-mail on pharmacovigilance@nafdac.gov.ng

For complaints, you can call the Reforms Unit on the following lines: 09097630506, 09097630507, or email: reforms@nafdac.gov.ng

Furthermore, note that this notice will be uploaded to the WHO Global Surveillance and Monitoring System (GSMS).

NAFDAC ………. Customer-focused, Agency-minded!!!

  • Content Current as of April 2, 2026 More Actions

Get daily alerts for NAFDAC Nigeria News & Alerts

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NAFDAC.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NAFDAC
Filed
March 25th, 2026
Instrument
Enforcement
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Substantive
Document ID
Public Alert No. 023/2026

Who this affects

Applies to
Healthcare providers Patients Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Product quality assurance Drug distribution Pharmacovigilance
Geographic scope
NG NG

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Clinical Operations
Compliance frameworks
GxP
Topics
Public Health Product Safety

Get alerts for this source

We'll email you when NAFDAC Nigeria News & Alerts publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!